Dyne Therapeutics, Inc. DYN Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s accounts payable?
- Dyne Therapeutics, Inc. (DYN) reported accounts payable of $10.78M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s accounts payable changed year-over-year?
- Dyne Therapeutics, Inc.'s accounts payable increased by 53.6% year-over-year, from $7.02M to $10.78M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s accounts payable has grown at a 18.6% compound annual growth rate (CAGR), from $3.44M to $8.08M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.